Helius Medical Stock (NASDAQ:HSDT)
Previous Close
$1.14
52W Range
$0.80 - $24.00
50D Avg
$4.38
200D Avg
$7.91
Market Cap
$575.59K
Avg Vol (3M)
$733.93K
Beta
1.13
Div Yield
-
HSDT Company Profile
Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-invasive technologies for the treatment of symptoms caused by neurological disease or trauma. Its product, Portable Neuromodulation Stimulator (PoNS), is a non-surgical medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise. The company is headquartered in Newtown, Pennsylvania.